tiprankstipranks
Trending News
More News >
Percheron Therapeutics Limited (AU:PER)
OTHER OTC:PER
Australian Market

Percheron Therapeutics (PER) Financial Statements

Compare
13 Followers

Percheron Therapeutics Financial Overview

Percheron Therapeutics's market cap is currently AU$9.79M. The company's EPS TTM is AU$-0.006; its P/E ratio is -0.67; Percheron Therapeutics is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Gross ProfitAU$ -67.98KAU$ -79.42KAU$ -95.20KAU$ -89.22KAU$ -103.32K
Operating IncomeAU$ -16.71MAU$ -14.88MAU$ -13.34MAU$ -7.61MAU$ -8.68M
EBITDAAU$ -16.27MAU$ -11.84MAU$ -13.25MAU$ -7.52MAU$ -8.58M
Net IncomeAU$ -14.92MAU$ -11.92MAU$ -11.38MAU$ -5.81MAU$ -8.06M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 10.17MAU$ 11.87MAU$ 10.97MAU$ 19.23MAU$ 6.02M
Total AssetsAU$ 12.44MAU$ 14.53MAU$ 12.84MAU$ 22.44MAU$ 7.00M
Total DebtAU$ 25.86KAU$ 39.87KAU$ 142.10KAU$ 227.40KAU$ 306.85K
Net DebtAU$ -10.14MAU$ -11.83MAU$ -10.83MAU$ -19.01MAU$ -5.71M
Total LiabilitiesAU$ 2.43MAU$ 5.17MAU$ 2.87MAU$ 1.30MAU$ 1.27M
Stockholders' EquityAU$ 10.00MAU$ 9.36MAU$ 9.98MAU$ 21.14MAU$ 5.73M
Cash Flow
Free Cash FlowAU$ -15.65MAU$ -10.12MAU$ -8.18MAU$ -7.81MAU$ -5.84M
Operating Cash FlowAU$ -15.64MAU$ -10.12MAU$ -8.15MAU$ -7.81MAU$ -5.83M
Investing Cash FlowAU$ -7.24KAU$ -3.61KAU$ -29.29KAU$ -3.91KAU$ -8.35K
Financing Cash FlowAU$ 13.95MAU$ 11.02MAU$ -85.30KAU$ 21.02MAU$ 7.80M
Currency in AUD

Percheron Therapeutics Earnings and Revenue History

Percheron Therapeutics Debt to Assets

Percheron Therapeutics Cash Flow

Percheron Therapeutics Forecast EPS vs Actual EPS